CINACALECT HYDROCHLORIDE TABLETS
Drug Names
Generic Name: CINACALECT HYDROCHLORIDE TABLETS
Usage and Dosage:
This product should be taken orally with an initial dose of 25mg (1 tablet) for adults once daily. The medicine should be taken with a meal or immediately after a meal. The medication should be swallowed whole and is not recommended to be cut and taken. The dose may be gradually increased from 25 mg to 75 mg once daily based on adequate observation of the patient's intact parathyroid hormone (iPTH) and serum calcium and serum phosphorus concentrations. If hyperparathyroidism remains uncorrected, a maximum dose of 100 mg per day may be given. incremental adjustments should be made in increments of 25 mg at a time, with intervals between incremental adjustments of not less than 3 weeks.
Indication:
This product is used for the treatment of secondary hyperparathyroidism in patients on maintenance dialysis for chronic kidney disease (CKD). It has the following advantages:
1. Compared with Paricalcitol, it is applicable to a wider range of people, and is suitable for patients with abdominal dialysis and hemodialysis.
2. Balanced regulation of blood calcium, phosphorus, calcium-phosphorus product and PTH levels in patients with chronic kidney disease.
3. Alternative to parathyroidectomy, avoiding the risk of surgery.
4. Reduce the incidence of cardiovascular and cerebrovascular events, with higher safety.
5. Original research quality is guaranteed, oral dosage form is more convenient.
Specification
25MG
Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.
Audited Supplier 
){kind=link}